Foundations Investment Advisors, LLC Iovance Biotherapeutics, Inc. Transaction History

Foundations Investment Advisors, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 19, 2023	SELL	$5.36 - $9.06 $3,044 - $5,146	-568 Reduced 3.64%	15,041 $105,000
Q1 2023 Apr 25, 2023	SELL	$5.53 - $8.22 $2,919 - $4,340	-528 Reduced 3.27%	15,609 $95,000
Q4 2022 Jan 11, 2023	SELL	$5.62 - $10.0 $12,684 - $22,570	-2,257 Reduced 12.27%	16,137 $0
Q3 2022 Oct 19, 2022	SELL	$9.53 - $13.11 $12,141 - $16,702	-1,274 Reduced 6.48%	18,394 $176,000
Q2 2022 Jul 08, 2022	SELL	$6.38 - $18.33 $625 - $1,796	-98 Reduced 0.5%	19,668 $236,000
Q4 2021 Jan 21, 2022	SELL	$16.55 - $27.63 $2,151 - $3,591	-130 Reduced 0.65%	19,766 $296,000
Q3 2021 Oct 13, 2021	BUY	$20.35 - $26.63 $71,265 - $93,258	3,502 Added 21.36%	19,896 $520,000
Q2 2021 Jul 14, 2021	BUY	$16.33 - $33.07 $267,714 - $542,149	16,394 New	16,394 $437,000

320

238M

1.27M

1.68M

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.74B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

Get notified when there are updates to the investment portfolio of Foundations Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Foundations Investment Advisors, LLC with notifications on news.